https://www.azarlab.com/research/medetomidine-objective-withdrawal-scale 2026-03-27 https://www.azarlab.com/research/understanding-the-mental-health-and-recovery-needs-of-canadian-youth-with-mental-health-disorders 2025-08-06 https://www.azarlab.com/research/drug-use-patterns-associated-with-risk-of-non-adherence-to-antiretroviral-therapy-among-hiv-positive-illicit-drug-users-in-a-canadian-setting 2025-08-06 https://www.azarlab.com/research/a-call-for-an-evidence-based-strategy-against-the-overdose-crisis 2025-08-06 https://www.azarlab.com/research/towards-an-international-consensus-on-the-prevention%2C-treatment-and-management-of-high-risk-substance-use-and-overdose-among-youth 2025-08-06 https://www.azarlab.com/research/short-communication%3A-systematic-review-on-effectiveness-of-micro-induction-approaches-to-buprenorphine-initiation 2025-08-06 https://www.azarlab.com/research/microdosing-and-standard-dosing-take-home-buprenorphine-from-the-emergency-department%3A-a-feasibility-study 2025-08-06 https://www.azarlab.com/research/development-of-a-graphene-oxide-deposited-carbon-electrode-for-the-rapid-and-low-level-detection-of-fentanyl-and-derivatives 2025-08-06 https://www.azarlab.com/research/systematic-review-on-intentional-non-medical-fentanyl-use-among-people-who-use-drugs 2025-08-06 https://www.azarlab.com/research/case-report%3A-successful-induction-of-buprenorphine%2Fnaloxone-using-a-microdosing-schedule-and-assertive-outreach 2025-08-06 https://www.azarlab.com/research/case-report%3A-acute-care-management-of-severe-opioid-withdrawal-with-iv-fentanyl 2025-08-06 https://www.azarlab.com/research/buprenorphine%2Fnaloxone-induction-for-treatment-of-acute-on-chronic-pain-using-a-micro-dosing-regimen%3A-a-case-report 2025-08-06 https://www.azarlab.com/research/comparing-rapid-micro-induction-and-standard-induction-of-buprenorphine%2Fnaloxone-for-treatment-of-opioid-use-disorder%3A-protocol-for-an-open-label%2C-parallel-group%2C-superiority%2C-randomized-controlled-trial 2025-08-06 https://www.azarlab.com/research/rapid-induction-of-buprenorphine%2Fnaloxone-for-chronic-pain-using-a-microdosing-regimen%3A-a-case-report 2025-08-06 https://www.azarlab.com/research/methadone-to-buprenorphine%2Fnaloxone-induction-without-withdrawal-utilizing-transdermal-fentanyl-bridge-in-an-inpatient-setting%E2%80%94azar-method 2025-08-06 https://www.azarlab.com/research/a-review-of-novel-methods-to-support-the-transition-from-methadone-and-other-full-agonist-opioids-to-buprenorphine%2Fnaloxone-sublingual-in-both-community-and-acute-care-settings 2025-08-06